x.com· @ · X·· 2026-04-22Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Super excited to have our simultaneous publication in @CD_AACR concurrent with #AACR26 talk by @MundAndreas @OmicVision on Deep Visual Proteomics (DVP) of #PancreaticCancer precursor lesions, the largest high resolution proteomics dataset of PanIN lesions.
https://t.co/7h4Aae4OOT https://t.co/yjE9yXJVVK
Heat 160 · 127 likes · 4 replies · 29 reposts
Source: x.com · x.com